PMID- 30628767
OWN - NLM
STAT- MEDLINE
DCOM- 20190325
LR  - 20240124
IS  - 2162-0989 (Electronic)
IS  - 2162-0989 (Linking)
VI  - 8
IP  - 1
DP  - 2019 Jan-Feb
TI  - Postoperative Adverse Events, Interventions, and the Utility of Routine Follow-Up 
      After 23-, 25-, and 27-Gauge Pars Plana Vitrectomy.
PG  - 36-42
LID - 10.22608/APO.2018398 [doi]
AB  - PURPOSE: To evaluate the utility of standard postoperative visit (POV) intervals 
      in pars plana vitrectomy (PPV) as a function of adverse events (AEs) identified. 
      DESIGN: Retrospective case review. METHODS: The medical records of all patients 
      undergoing 23-, 25-, and 27-gauge PPV from January 1, 2016 to December 31, 2016 
      were reviewed. Each POV was assessed as a standard (s-POV), physicianadjusted 
      (a-POV), or patient-initiated visit (p-POV). Preoperative features, diagnoses, 
      and surgical procedures were evaluated to determine protective and risk factors 
      for AEs. RESULTS: A total of 256 patients (310 PPVs) were included in this study. 
      The most common cumulative postoperative AEs were elevated intraocular pressure 
      (>30 mm Hg) (12.3%), cystoid macular edema (6.1%), and retinal detachment (5.8%). 
      Patients with the diagnosis of macular hole or epiretinal membrane had the lowest 
      relative risk of AEs [0.30; 95% confidence interval (CI), 0.12-0.75 and 0.36; 95% 
      CI, 0.21-0.63, respectively]. There was no difference in time to AE among 
      different vitrectomy gauge sizes (P = 0.733). Patients in a-POV and p-POV groups 
      had a statistically significant higher incidence of AEs in the POV day 5-10 
      window (P = 0.004). CONCLUSIONS: The utility of standard POVs in detecting AEs is 
      dependent on the indication for PPV. Specifically patients undergoing isolated 
      macular surgery (epiretinal membrane peel or macular hole repair) had the lowest 
      relative risk of postoperative AEs and may warrant a less-intensive follow-up 
      regimen.
CI  - Copyright 2019 Asia-Pacific Academy of Ophthalmology.
FAU - Shields, Ryan A
AU  - Shields RA
AD  - Byers Eye Institute, Department of Ophthalmology, Stanford University School of 
      Medicine, Palo Alto, CA, United States.
FAU - Ludwig, Cassie A
AU  - Ludwig CA
AD  - Byers Eye Institute, Department of Ophthalmology, Stanford University School of 
      Medicine, Palo Alto, CA, United States.
FAU - Powers, Matthew A
AU  - Powers MA
AD  - Byers Eye Institute, Department of Ophthalmology, Stanford University School of 
      Medicine, Palo Alto, CA, United States.
FAU - Tran, Elaine M T
AU  - Tran EMT
AD  - Byers Eye Institute, Department of Ophthalmology, Stanford University School of 
      Medicine, Palo Alto, CA, United States.
FAU - Smith, Stephen J
AU  - Smith SJ
AD  - Byers Eye Institute, Department of Ophthalmology, Stanford University School of 
      Medicine, Palo Alto, CA, United States.
FAU - Moshfeghi, Darius M
AU  - Moshfeghi DM
AD  - Byers Eye Institute, Department of Ophthalmology, Stanford University School of 
      Medicine, Palo Alto, CA, United States.
LA  - eng
PT  - Journal Article
DEP - 20190110
PL  - United States
TA  - Asia Pac J Ophthalmol (Phila)
JT  - Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
JID - 101583622
SB  - IM
MH  - Aged
MH  - Epiretinal Membrane/surgery
MH  - Eye Diseases/*surgery
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Intraocular Pressure/physiology
MH  - Male
MH  - Middle Aged
MH  - Ocular Hypertension/complications
MH  - Postoperative Complications/*etiology/physiopathology
MH  - Retinal Detachment/etiology
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Vitrectomy/*adverse effects/methods
OTO - NOTNLM
OT  - adverse events
OT  - follow-up
OT  - macular surgery
OT  - vitrectomy
OT  - vitrectomy gauge
EDAT- 2019/01/11 06:00
MHDA- 2019/03/26 06:00
CRDT- 2019/01/11 06:00
PHST- 2019/01/11 06:00 [pubmed]
PHST- 2019/03/26 06:00 [medline]
PHST- 2019/01/11 06:00 [entrez]
AID - S2162-0989(23)01044-7 [pii]
AID - 10.22608/APO.2018398 [doi]
PST - ppublish
SO  - Asia Pac J Ophthalmol (Phila). 2019 Jan-Feb;8(1):36-42. doi: 
      10.22608/APO.2018398. Epub 2019 Jan 10.